Both Izervay and Syfovre are eye injections used to treat geographic atrophy caused by AMD. They work similarly to one another to manage this condition. Because of this, they can cause some ...

Apellis reported robust growth in Q2 2024, with its drugs SYFOVRE and EMPAVELI performing well. SYFOVRE achieved over $0.5 billion in sales since its launch and $155 million in net product revenue ...

The firm's stance comes ahead of the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) expected final opinion on the approval of Apellis's drug pegcetacoplan ...

The US regulator has cleared the company’s complement C3 inhibitor pegcetacoplan as an intravitreal injection called Syfovre for GA, which affects more than 5 million people worldwide ...

in participants treated with pegcetacoplan therapy (Syfovre; Apellis Pharmaceuticals). She is a professor and the chair of the Department of Ophthalmology at the Medical University of Vienna in ...

After hours: September 20 at 7:57 PM EDT Loading Chart for APLS ...